February 2010
Second-Generation Antipsychotics: New Information
Second-generation antipsychotics differ from each other, offering options for patients.
Cognitive Effects of Antipsychotic Drugs: Are All Created Equal?
First- and second-generation antipsychotics appear comparable in their ability to lessen cognitive dysfunction associated with schizophrenia.
In Brief
Long-acting Injectable Olanzapine Approved in US; High-potency Cannabis May Increase Risk of Psychosis
Olanzapine and Sertraline Combined for Psychotic Depression
In a short-term trial, sertraline (Zoloft and others) combined with olanzapine (Zyprexa) was more efficacious than olanzapine plus placebo for psychotic depression in both young and elderly patients.
In Brief
February 2010
The US Food and Drug Administration approved an extended-release injectable suspension preparation of olanzapine (Zyprexa Relprevv) on December 11, 2009, for the treatment of schizophrenia in adults. It is a long-acting atypical antipsychotic for deep intramuscular gluteal injection. We reviewed this…
To view the rest of this article, please:
For current
BTP subscribers
Purchase access
to all articles
Purchase this article
for $3 (USD)